OriGene Email Format

Biotechnology ResearchMaryland, United States51-200 Employees

OriGene Technologies is a biotechnology research company based in Rockville, Maryland, with a workforce of 51 to 200 employees. The company focuses on developing genome-wide research tools and platforms to enable studies of complete biological pathways and disease mechanisms, including cancer and stem cell research. Its flagship cDNA resource comprises a collection of over 30,000 TrueClone human full-length cDNA clones and more than 25,000 TrueORF cDNA clones. From its TrueORF cDNA clones, OriGene has developed full-length human proteins expressed in mammalian cells for functional research assays. OriGene has expanded its offerings to include monoclonal antibodies and biomarker tools through the TrueMAB project, initiated in 2010 to develop mouse monoclonal antibodies against protein antigens, as well as TissueScan cancer tissue qPCR arrays and a tissue biorepository for biomarker discovery and validation. In December 2025, the company announced the launch of ProteanFect, a coacervate-based gene delivery reagent designed to enhance transfection performance across a broad range of cell systems.

Sign up for free to view info

Company overview Employee directory